Global Widget recently took part of a first-of-its-kind CBD industry clinical study examining the effect of CBD products on liver health. Validcare, which conducts patient-centered clinical trials, reported no preliminary evidence of liver disease in the more than 800 adults taking part in the study. Patrick McCarthy, CEO of Validcare, joins Global Widget Chief Compliance and Legal Officer Margaret Richardson to discuss the preliminary results of the study, Global Widget’s mission to produce safe, compliant, effective products and Validcare’s meeting with the FDA on the study.